Peptide therapy TikTok trends: separating hype from evidence

What did @brendaclips2 actually say?

Bluntly: nothing about peptides, health, or science. The transcript is a short social exchange between two people comparing ages. One person is 24, the other is 23, and the exchange ends with someone noting they are "a little bit older." There is no health claim here. No peptide is named, no protocol is described, no benefit is promised.

The full transcript reads as a casual, lighthearted conversation: "How old are you Kanita?" "24." "You are a small baby girl." "I'm a little bit older than you." That is the entirety of the content. It is a social media clip about two young women playfully ribbing each other about their ages. There is nothing here that resembles health advice, peptide therapy discussion, or any claim about longevity or optimization.

Does the science back this up?

There is no scientific claim in this video to evaluate. Assigning a peptide fact-check to this content would itself be misleading, so we are not going to manufacture one. The video was categorized under peptide therapy, but the transcript contains zero references to BPC-157, TB-500, GHK-Cu, ipamorelin, MK-677, semax, selank, or any other bioactive compound.

What we can say: age and biological aging are genuinely active areas of peptide research. Compounds like Epithalon have been studied in the context of telomere extension and aging, with early work from Khavinson et al. (2003, Annals of the New York Academy of Sciences) suggesting modest effects in animal models. GHK-Cu has been researched for skin aging by Pickart and Margolina (2018, Biomolecules). But none of this is relevant to a 23-year-old and a 24-year-old joking about who is older. Mapping serious clinical research onto this video would be a stretch that borders on absurd.

What did they get wrong (or right)?

Neither right nor wrong applies here in any meaningful clinical sense. The only factual claim in the video is that one person is 23 and one is 24, and that the 24-year-old is older. That is arithmetically correct.

What is worth noting is the categorization problem. When a video with no health content gets tagged under a medical category like peptide therapy, it creates a signal-to-noise issue for anyone trying to find legitimate clinical information. That is not the creator's fault necessarily, but it is worth naming. Platforms and tagging systems that apply health categories loosely can inadvertently dilute the quality of health information ecosystems. Viewers searching for real guidance on peptide use for recovery or longevity deserve content that actually addresses those topics, not age-comparison banter tagged with a corn emoji.

What should you actually know?

If you landed here hoping to learn something about peptide therapy and aging, here is a brief, honest summary of where the science actually stands. Peptides are short chains of amino acids that can influence cellular signaling. Some, like BPC-157, have shown tissue repair effects in rodent studies, though robust human clinical trials remain limited as of 2024. Others, like CJC-1295 combined with ipamorelin, are used off-label to stimulate growth hormone release, with research from Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) showing measurable GH elevation in adults.

The appeal of peptide therapy for younger adults, which 23 and 24 fall squarely into, is often framed around optimization and recovery rather than disease treatment. But it bears repeating: no compounded peptide has been approved by the FDA to treat, cure, or prevent any disease. Anyone presenting these compounds as cures is overstating the evidence. Consult a licensed provider before considering any peptide protocol.